_id
691b11ae3c536f8df2318aa2
Ticker
ALTME.PA
Name
TME Pharma N.V.
Exchange
PA
Address
Max-Dohrn-Strasse 8-10, Berlin, Germany, 10589
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.tmepharma.com
Description
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. The company's Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, and glioblastoma. It also developing NOX-E36, which has completed Phase 1/2a clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. in July 2022. TME Pharma N.V. was founded in 1997 and is headquartered in Berlin, Germany.
Last Close
0.068
Volume
98218
Current Price
0.067
Change
0
Last Updated
2025-12-30T12:42:56.548Z
Image
https://logo.clearbit.com/www.tmepharma.com
Ipo Date
-
Market Cap
6399828
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
27000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1977000
Operating Income
-1957000
Interest Expense
217000
Pretax Income
-2102000
Net Income
-2102000
Eps
-0.02233779806972732
Dividends Per Share
-
Shares Outstanding
94091417
Income Tax Expense
-
EBITDA
-1878000
Operating Margin
-7248.148148148148
Total Other Income Expense Net
-145000
Cash
2060000
Short Term Investments
4000
Receivables
31000
Inventories
-
Total Current Assets
2275000
Property Plant Equipment
9000
Total Assets
2293000
Payables
731000
Short Term Debt
1891000
Long Term Debt
-
Total Liabilities
2863000
Equity
-570000
Bs_currency_symbol
-
Depreciation
7000
Change In Working Capital
-858000
Cash From Operations
-2860000
Capital Expenditures
0
Cash From Investing
8000
Cash From Financing
1672000
Net Change In Cash
-1180000
Cf_currency_symbol
-
PE
-
PB
-11.06094666140351
ROE
368.77192982456137
ROA
-91.6703009158308
FCF
-2860000
Fcf Percent
-105.92592592592592
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
4
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
27000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1977000
Quarters > 0 > income Statement > operating Income
-1957000
Quarters > 0 > income Statement > interest Expense
217000
Quarters > 0 > income Statement > pretax Income
-2102000
Quarters > 0 > income Statement > net Income
-2102000
Quarters > 0 > income Statement > eps
-0.02233779806972732
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
94100591
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1878000
Quarters > 0 > income Statement > operating Margin
-7248.148148148148
Quarters > 0 > income Statement > total Other Income Expense Net
-145000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2060000
Quarters > 0 > balance Sheet > short Term Investments
4000
Quarters > 0 > balance Sheet > receivables
31000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2275000
Quarters > 0 > balance Sheet > property Plant Equipment
9000
Quarters > 0 > balance Sheet > total Assets
2293000
Quarters > 0 > balance Sheet > payables
731000
Quarters > 0 > balance Sheet > short Term Debt
1891000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2863000
Quarters > 0 > balance Sheet > equity
-570000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-2102000
Quarters > 0 > cash Flow > depreciation
7000
Quarters > 0 > cash Flow > change In Working Capital
-858000
Quarters > 0 > cash Flow > cash From Operations
-2860000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
8000
Quarters > 0 > cash Flow > cash From Financing
1672000
Quarters > 0 > cash Flow > net Change In Cash
-1180000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.02233779806972732
Quarters > 0 > ratios > PB
-11.06094666140351
Quarters > 0 > ratios > ROE
368.77192982456137
Quarters > 0 > ratios > ROA
-91.6703009158308
Quarters > 0 > ratios > FCF
-2860000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-105.92592592592592
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
19000
Quarters > 1 > income Statement > cost Of Revenue
12000
Quarters > 1 > income Statement > gross Profit
-12000
Quarters > 1 > income Statement > operating Expenses
2534000
Quarters > 1 > income Statement > operating Income
-2534000
Quarters > 1 > income Statement > interest Expense
2000
Quarters > 1 > income Statement > pretax Income
-2474000
Quarters > 1 > income Statement > net Income
-2474000
Quarters > 1 > income Statement > eps
-0.09046122573717671
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
27348734
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2506000
Quarters > 1 > income Statement > operating Margin
-13336.842105263158
Quarters > 1 > income Statement > total Other Income Expense Net
60000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
3240000
Quarters > 1 > balance Sheet > short Term Investments
5000
Quarters > 1 > balance Sheet > receivables
26000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3363000
Quarters > 1 > balance Sheet > property Plant Equipment
35000
Quarters > 1 > balance Sheet > total Assets
3406000
Quarters > 1 > balance Sheet > payables
1326000
Quarters > 1 > balance Sheet > short Term Debt
56000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
1792000
Quarters > 1 > balance Sheet > equity
1614000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-2474000
Quarters > 1 > cash Flow > depreciation
12000
Quarters > 1 > cash Flow > change In Working Capital
74000
Quarters > 1 > cash Flow > cash From Operations
-1899000
Quarters > 1 > cash Flow > capital Expenditures
12000
Quarters > 1 > cash Flow > cash From Investing
-13000
Quarters > 1 > cash Flow > cash From Financing
2458000
Quarters > 1 > cash Flow > net Change In Cash
537000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.09046122573717671
Quarters > 1 > ratios > PB
1.1352944101610905
Quarters > 1 > ratios > ROE
-153.28376703841388
Quarters > 1 > ratios > ROA
-72.63652378156195
Quarters > 1 > ratios > FCF
-1911000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-100.57894736842105
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
66000
Quarters > 2 > income Statement > gross Profit
-66000
Quarters > 2 > income Statement > operating Expenses
2677000
Quarters > 2 > income Statement > operating Income
-2743000
Quarters > 2 > income Statement > interest Expense
520000
Quarters > 2 > income Statement > pretax Income
-3248000
Quarters > 2 > income Statement > net Income
-3248000
Quarters > 2 > income Statement > eps
-0.11876235294840339
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27348734
Quarters > 2 > income Statement > income Tax Expense
15000
Quarters > 2 > income Statement > EBITDA
-2662000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-505000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
2703000
Quarters > 2 > balance Sheet > short Term Investments
4000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2899000
Quarters > 2 > balance Sheet > property Plant Equipment
34000
Quarters > 2 > balance Sheet > total Assets
2942000
Quarters > 2 > balance Sheet > payables
1039000
Quarters > 2 > balance Sheet > short Term Debt
123000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
1375000
Quarters > 2 > balance Sheet > equity
1567000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-3248000
Quarters > 2 > cash Flow > depreciation
66000
Quarters > 2 > cash Flow > change In Working Capital
-281000
Quarters > 2 > cash Flow > cash From Operations
-2737000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
-8000
Quarters > 2 > cash Flow > cash From Financing
3204000
Quarters > 2 > cash Flow > net Change In Cash
-305000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.11876235294840339
Quarters > 2 > ratios > PB
1.1693459974473517
Quarters > 2 > ratios > ROE
-207.275047862157
Quarters > 2 > ratios > ROA
-110.40108769544528
Quarters > 2 > ratios > FCF
-2741000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
17000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
17000
Quarters > 3 > income Statement > operating Expenses
-8362000
Quarters > 3 > income Statement > operating Income
-2840000
Quarters > 3 > income Statement > interest Expense
22000
Quarters > 3 > income Statement > pretax Income
-3075000
Quarters > 3 > income Statement > net Income
-3077000
Quarters > 3 > income Statement > eps
-0.46121119425669904
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6671564
Quarters > 3 > income Statement > income Tax Expense
2000
Quarters > 3 > income Statement > EBITDA
-2824500
Quarters > 3 > income Statement > operating Margin
-16705.88235294118
Quarters > 3 > income Statement > total Other Income Expense Net
-235000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
2245000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
41000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2386000
Quarters > 3 > balance Sheet > property Plant Equipment
96000
Quarters > 3 > balance Sheet > total Assets
2491000
Quarters > 3 > balance Sheet > payables
1167000
Quarters > 3 > balance Sheet > short Term Debt
1166000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
2785000
Quarters > 3 > balance Sheet > equity
-294000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-3077
Quarters > 3 > cash Flow > depreciation
66
Quarters > 3 > cash Flow > change In Working Capital
142
Quarters > 3 > cash Flow > cash From Operations
-2241
Quarters > 3 > cash Flow > capital Expenditures
19000
Quarters > 3 > cash Flow > cash From Investing
-19000
Quarters > 3 > cash Flow > cash From Financing
1476
Quarters > 3 > cash Flow > net Change In Cash
-381.5
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.46121119425669904
Quarters > 3 > ratios > PB
-1.5203904353741498
Quarters > 3 > ratios > ROE
1046.5986394557824
Quarters > 3 > ratios > ROA
-123.52468887996788
Quarters > 3 > ratios > FCF
-21241
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.249470588235294
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
19000
Annuals > 0 > income Statement > cost Of Revenue
78000
Annuals > 0 > income Statement > gross Profit
-78000
Annuals > 0 > income Statement > operating Expenses
5199000
Annuals > 0 > income Statement > operating Income
-5277000
Annuals > 0 > income Statement > interest Expense
503000
Annuals > 0 > income Statement > pretax Income
-5722000
Annuals > 0 > income Statement > net Income
-5722000
Annuals > 0 > income Statement > eps
-0.2092235786855801
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
27348734
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5245000
Annuals > 0 > income Statement > operating Margin
-27773.684210526317
Annuals > 0 > income Statement > total Other Income Expense Net
-445000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
3240000
Annuals > 0 > balance Sheet > short Term Investments
5000
Annuals > 0 > balance Sheet > receivables
26000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3363000
Annuals > 0 > balance Sheet > property Plant Equipment
35000
Annuals > 0 > balance Sheet > total Assets
3406000
Annuals > 0 > balance Sheet > payables
1326000
Annuals > 0 > balance Sheet > short Term Debt
56000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
1792000
Annuals > 0 > balance Sheet > equity
1614000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-5722000
Annuals > 0 > cash Flow > depreciation
78000
Annuals > 0 > cash Flow > change In Working Capital
217000
Annuals > 0 > cash Flow > cash From Operations
-4634000
Annuals > 0 > cash Flow > capital Expenditures
16000
Annuals > 0 > cash Flow > cash From Investing
-21000
Annuals > 0 > cash Flow > cash From Financing
5660000
Annuals > 0 > cash Flow > net Change In Cash
995000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.2092235786855801
Annuals > 0 > ratios > PB
1.1691837955390334
Annuals > 0 > ratios > ROE
-354.52292441140025
Annuals > 0 > ratios > ROA
-167.99765120375807
Annuals > 0 > ratios > FCF
-4650000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-244.73684210526315
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
17000
Annuals > 1 > income Statement > cost Of Revenue
144000
Annuals > 1 > income Statement > gross Profit
-127000
Annuals > 1 > income Statement > operating Expenses
5497000
Annuals > 1 > income Statement > operating Income
-5624000
Annuals > 1 > income Statement > interest Expense
1518000
Annuals > 1 > income Statement > pretax Income
-6734000
Annuals > 1 > income Statement > net Income
-6736000
Annuals > 1 > income Statement > eps
-1.3422059202120749
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5018604
Annuals > 1 > income Statement > income Tax Expense
2000
Annuals > 1 > income Statement > EBITDA
-5072000
Annuals > 1 > income Statement > operating Margin
-33082.35294117647
Annuals > 1 > income Statement > total Other Income Expense Net
-1110000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2245000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
41000
Annuals > 1 > balance Sheet > inventories
91000
Annuals > 1 > balance Sheet > total Current Assets
2386000
Annuals > 1 > balance Sheet > property Plant Equipment
96000
Annuals > 1 > balance Sheet > total Assets
2491000
Annuals > 1 > balance Sheet > payables
1167000
Annuals > 1 > balance Sheet > short Term Debt
1166000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
2785000
Annuals > 1 > balance Sheet > equity
-294000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-6734000
Annuals > 1 > cash Flow > depreciation
144000
Annuals > 1 > cash Flow > change In Working Capital
-555000
Annuals > 1 > cash Flow > cash From Operations
-5635000
Annuals > 1 > cash Flow > capital Expenditures
19000
Annuals > 1 > cash Flow > cash From Investing
-19000
Annuals > 1 > cash Flow > cash From Financing
3266000
Annuals > 1 > cash Flow > net Change In Cash
-2389000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.3422059202120749
Annuals > 1 > ratios > PB
-1.1778356326530612
Annuals > 1 > ratios > ROE
2291.1564625850338
Annuals > 1 > ratios > ROA
-270.4134885588117
Annuals > 1 > ratios > FCF
-5654000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-332.5882352941176
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
92000
Annuals > 2 > income Statement > gross Profit
-92000
Annuals > 2 > income Statement > operating Expenses
11996000
Annuals > 2 > income Statement > operating Income
-12029000
Annuals > 2 > income Statement > interest Expense
3400000
Annuals > 2 > income Statement > pretax Income
-15126000
Annuals > 2 > income Statement > net Income
-15132000
Annuals > 2 > income Statement > eps
-12.863332616436876
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1176367
Annuals > 2 > income Statement > income Tax Expense
7000
Annuals > 2 > income Statement > EBITDA
-11634000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-3097000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
4634000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
279000
Annuals > 2 > balance Sheet > inventories
74000
Annuals > 2 > balance Sheet > total Current Assets
5011000
Annuals > 2 > balance Sheet > property Plant Equipment
221000
Annuals > 2 > balance Sheet > total Assets
5241000
Annuals > 2 > balance Sheet > payables
1695000
Annuals > 2 > balance Sheet > short Term Debt
4019000
Annuals > 2 > balance Sheet > long Term Debt
67000
Annuals > 2 > balance Sheet > total Liabilities
6513000
Annuals > 2 > balance Sheet > equity
-1272000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-15126000
Annuals > 2 > cash Flow > depreciation
92000
Annuals > 2 > cash Flow > change In Working Capital
-720000
Annuals > 2 > cash Flow > cash From Operations
-12143000
Annuals > 2 > cash Flow > capital Expenditures
21000
Annuals > 2 > cash Flow > cash From Investing
-21000
Annuals > 2 > cash Flow > cash From Financing
7285000
Annuals > 2 > cash Flow > net Change In Cash
-4822000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-12.863332616436876
Annuals > 2 > ratios > PB
-0.0638123608490566
Annuals > 2 > ratios > ROE
1189.622641509434
Annuals > 2 > ratios > ROA
-288.72352604464794
Annuals > 2 > ratios > FCF
-12164000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
33000
Annuals > 3 > income Statement > cost Of Revenue
66000
Annuals > 3 > income Statement > gross Profit
-65967
Annuals > 3 > income Statement > operating Expenses
13451000
Annuals > 3 > income Statement > operating Income
-13267000
Annuals > 3 > income Statement > interest Expense
1504000
Annuals > 3 > income Statement > pretax Income
-14452000
Annuals > 3 > income Statement > net Income
-14452000
Annuals > 3 > income Statement > eps
-21.90194741229067
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
659850
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-12882000
Annuals > 3 > income Statement > operating Margin
-40203.030303030304
Annuals > 3 > income Statement > total Other Income Expense Net
-1185000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
9456000
Annuals > 3 > balance Sheet > short Term Investments
28000
Annuals > 3 > balance Sheet > receivables
81000
Annuals > 3 > balance Sheet > inventories
124000
Annuals > 3 > balance Sheet > total Current Assets
9693000
Annuals > 3 > balance Sheet > property Plant Equipment
66000
Annuals > 3 > balance Sheet > total Assets
9768000
Annuals > 3 > balance Sheet > payables
2235000
Annuals > 3 > balance Sheet > short Term Debt
2440000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
5266000
Annuals > 3 > balance Sheet > equity
4515000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-14452000
Annuals > 3 > cash Flow > depreciation
66000
Annuals > 3 > cash Flow > change In Working Capital
407000
Annuals > 3 > cash Flow > cash From Operations
-12381000
Annuals > 3 > cash Flow > capital Expenditures
14000
Annuals > 3 > cash Flow > cash From Investing
-14000
Annuals > 3 > cash Flow > cash From Financing
11498000
Annuals > 3 > cash Flow > net Change In Cash
-848000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-21.90194741229067
Annuals > 3 > ratios > PB
0.010084086378737544
Annuals > 3 > ratios > ROE
-320.0885935769657
Annuals > 3 > ratios > ROA
-147.95249795249796
Annuals > 3 > ratios > FCF
-12395000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-375.6060606060606
Annuals > 3 > health Score
23
Valuation > metrics > PE
-0.02233779806972732
Valuation > metrics > PB
-11.06094666140351
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
368.77192982456137
Profitability > metrics > ROA
-92.3956043956044
Profitability > metrics > Net Margin
-77.85185185185185
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-9.018433179723502
Risk > final Score
-6
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.8676582761250954
Liquidity > metrics > Quick Ratio
0.8676582761250954
Liquidity > final Score
53
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
40
Prev Risks > 0
-5038
Prev Risks > 1
27
Prev Risks > 2
-486
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
76
Updated At
2026-01-20T23:09:17.420Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.02
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.02
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-25
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.06
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.06
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-10-18
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.12
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.12
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-24
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-12.86
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-12.86
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-10-26
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-1146.92
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1146.92
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-04-22
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.11
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.11
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-10-26
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.11
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-28
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.11
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.11
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-10-29
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.26
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.26
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-04-22
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.09
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.09
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-10-24
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.19
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.19
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-04-12
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-1.2
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-1.2
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-10-11
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-1.7
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-1.7
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-04-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-1.35
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-1.35
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-30
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-6.71
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-6.71
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-31
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-42.49
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-42.49
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-27
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-5.5
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-5.5
Earnings History > 16 > surprise Percent
-
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. The company's Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, and glioblastoma. It also developing NOX-E36, which has completed Phase 1/2a clinical trial for the treatment of diabetic nephropathy. The company was formerly known as NOXXON Pharma N.V. and changed its name to TME Pharma N.V. in July 2022. TME Pharma N.V. was founded in 1997 and is headquartered in Berlin, Germany.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATME Pharma announces receipt of agreements in principle to extend certain bond agreements Yahoo Finance
Read more →Showing 2 of 5
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of TME Pharma N.V.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.02
EPS Estimate
0
EPS Difference
-0.02
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.